The Royal Wolverhampton NHS Trust<\/del><\/p>University Hospitals of North Midlands NHS Trust<\/ins><\/p> <\/p><\/td> £32,420,000<\/p><\/td><\/tr> | University Hospitals of North Midlands NHS Trust<\/del><\/p>The Royal Wolverhampton NHS Trust<\/ins><\/p><\/td>£5,480,000<\/p><\/td><\/tr> | Grand Total<\/p><\/td> | £37,900,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The amount of public dividend capital issued to the Trust by the Department is as follows:<\/p> <\/p> <\/p> <\/p> 2009/10<\/p><\/td> | £214,000<\/p><\/td><\/tr> | 2010/11<\/p><\/td> | £0<\/p><\/td><\/tr> | 2011/12<\/p><\/td> | £21,000,000<\/p><\/td><\/tr> | 2012/13<\/p><\/td> | £21,385,000<\/p><\/td><\/tr> | 2013/14<\/p><\/td> | £30,397,000<\/p><\/td><\/tr> | 2014/15<\/p><\/td> | £64,425,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.<\/p> <\/p> <\/p> <\/p> The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.<\/p> <\/p> <\/p> <\/p> The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.<\/p> <\/p> <\/p> <\/p> The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA\u2019s recommendations.<\/p> <\/p> <\/p> <\/p> We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.<\/p> <\/p> <\/p> <\/p> In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:<\/p> <\/p> <\/p> <\/p> (a) accommodation;<\/p> <\/p> (b) travel (car, taxi and train);<\/p> <\/p> (c) subsistence; and<\/p> <\/p> (d) other expenses incurred; and what other costs to the TSA were incurred<\/p> <\/p> <\/p> <\/p> Breakdown of expenses, these exclude VAT:<\/p> <\/p> <\/p> <\/p> | <\/td> | TSA1<\/p><\/td> | TSA2<\/p><\/td> | Total<\/p><\/td><\/tr> | Accommodation<\/p><\/td> | £82,242.89<\/p><\/td> | £170,622.67<\/p><\/td> | £252,865.56<\/p><\/td><\/tr> | Travel<\/p><\/td> | £144,122.38<\/p><\/td> | £226,600.29<\/p><\/td> | £370,722.67<\/p><\/td><\/tr> | Subsistence<\/p><\/td> | £16,171.73<\/p><\/td> | £43,176.88<\/p><\/td> | £59,348.61<\/p><\/td><\/tr> | Other (incidentals such as printing, room hire and meeting refreshments)<\/p><\/td> | £1,939.11<\/p><\/td> | £3052.73<\/p><\/td> | £4991.84<\/p><\/td><\/tr> | Total<\/p><\/td> | £244,476.11<\/p><\/td> | £443,452.57<\/p><\/td> | £687,928.68<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-03-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/224722/answer/previousversion/49060", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2015-03-10T17:13:10.567Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-17T16:58:22.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mid Staffordshire NHS Foundation Trust"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what (a) public dividend capital and (b) other non-tariff payments have been made to the Mid-Stafforshire NHS Foundation Trust in (i) 2009-10, (ii) 2010-11, (iii) 2011-12, (iv) 2012-13, (v) 2013-14 and (vi) 2014-15 to date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4109", "label" : {"_value" : "Biography information for Jeremy Lefroy"}
}
, "tablingMemberConstituency" : {"_value" : "Stafford"}
, "tablingMemberPrinted" : [{"_value" : "Jeremy Lefroy"}
], "uin" : "225961"}
, {"_about" : "http://data.parliament.uk/resources/224723", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/224723/answer", "answerText" : {"_value" : " The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.<\/p> <\/p> <\/p> <\/p> The capital provided to date is as follows:<\/p> <\/p> <\/p> <\/p> The Royal Wolverhampton NHS Trust<\/p><\/td> | £12,109,000<\/p><\/td><\/tr> | University Hospitals of North Midlands NHS Trust<\/p><\/td> | £12,153,000<\/p><\/td><\/tr> | Walsall Healthcare NHS Trust<\/p><\/td> | £4,000,000<\/p><\/td><\/tr> | Grand Total<\/p><\/td> | £28,262,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> Revenue funding provided to date is set out in the following table:<\/p> <\/p> <\/p> <\/p> The Royal Wolverhampton NHS Trust<\/del><\/p>University Hospitals of North Midlands NHS Trust<\/ins><\/p><\/td>£32,420,000<\/p><\/td><\/tr> | University Hospitals of North Midlands NHS Trust<\/del><\/p>The Royal Wolverhampton NHS Trust<\/ins><\/p><\/td>£5,480,000<\/p><\/td><\/tr> | Grand Total<\/p><\/td> | £37,900,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The amount of public dividend capital issued to the Trust by the Department is as follows:<\/p> <\/p> <\/p> <\/p> 2009/10<\/p><\/td> | £214,000<\/p><\/td><\/tr> | 2010/11<\/p><\/td> | £0<\/p><\/td><\/tr> | 2011/12<\/p><\/td> | £21,000,000<\/p><\/td><\/tr> | 2012/13<\/p><\/td> | £21,385,000<\/p><\/td><\/tr> | 2013/14<\/p><\/td> | £30,397,000<\/p><\/td><\/tr> | 2014/15<\/p><\/td> | £64,425,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.<\/p> <\/p> <\/p> <\/p> The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.<\/p> <\/p> <\/p> <\/p> The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.<\/p> <\/p> <\/p> <\/p> The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA\u2019s recommendations.<\/p> <\/p> <\/p> <\/p> We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.<\/p> <\/p> <\/p> <\/p> In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:<\/p> <\/p> <\/p> <\/p> (a) accommodation;<\/p> <\/p> (b) travel (car, taxi and train);<\/p> <\/p> (c) subsistence; and<\/p> <\/p> (d) other expenses incurred; and what other costs to the TSA were incurred<\/p> <\/p> <\/p> <\/p> Breakdown of expenses, these exclude VAT:<\/p> <\/p> <\/p> <\/p> | <\/td> | TSA1<\/p><\/td> | TSA2<\/p><\/td> | Total<\/p><\/td><\/tr> | Accommodation<\/p><\/td> | £82,242.89<\/p><\/td> | £170,622.67<\/p><\/td> | £252,865.56<\/p><\/td><\/tr> | Travel<\/p><\/td> | £144,122.38<\/p><\/td> | £226,600.29<\/p><\/td> | £370,722.67<\/p><\/td><\/tr> | Subsistence<\/p><\/td> | £16,171.73<\/p><\/td> | £43,176.88<\/p><\/td> | £59,348.61<\/p><\/td><\/tr> | Other (incidentals such as printing, room hire and meeting refreshments)<\/p><\/td> | £1,939.11<\/p><\/td> | £3052.73<\/p><\/td> | £4991.84<\/p><\/td><\/tr> | Total<\/p><\/td> | £244,476.11<\/p><\/td> | £443,452.57<\/p><\/td> | £687,928.68<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-03-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/224723/answer/previousversion/49061", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2015-03-10T17:13:10.723Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-17T17:12:17.633Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mid Staffordshire NHS Foundation Trust"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many consultants have been employed by the Trust Special Administration (TSA) of the Mid-Staffordshire NHS Foundation Trust since its inception; how many person-days they have worked; what (a) accommodation, (b) travel, (c) subsistence and (d) other expenses they have incurred; and what other costs to the TSA they have incurred.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4109", "label" : {"_value" : "Biography information for Jeremy Lefroy"}
}
, "tablingMemberConstituency" : {"_value" : "Stafford"}
, "tablingMemberPrinted" : [{"_value" : "Jeremy Lefroy"}
], "uin" : "225962"}
, {"_about" : "http://data.parliament.uk/resources/224727", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/224727/answer", "answerText" : {"_value" : " The Department holds records of the total capital allocated to the respective recipient bodies as a result of the transfer of Mid-Staffordshire NHS Foundation Trust services but does not have details of the breakdown by individual hospital site.<\/p> <\/p> <\/p> <\/p> The capital provided to date is as follows:<\/p> <\/p> <\/p> <\/p> The Royal Wolverhampton NHS Trust<\/p><\/td> | £12,109,000<\/p><\/td><\/tr> | University Hospitals of North Midlands NHS Trust<\/p><\/td> | £12,153,000<\/p><\/td><\/tr> | Walsall Healthcare NHS Trust<\/p><\/td> | £4,000,000<\/p><\/td><\/tr> | Grand Total<\/p><\/td> | £28,262,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> Revenue funding provided to date is set out in the following table:<\/p> <\/p> <\/p> <\/p> The Royal Wolverhampton NHS Trust<\/del><\/p>University Hospitals of North Midlands NHS Trust<\/ins><\/p><\/td>£32,420,000<\/p><\/td><\/tr> | University Hospitals of North Midlands NHS Trust<\/del><\/p>The Royal Wolverhampton NHS Trust<\/ins><\/p><\/td>£5,480,000<\/p><\/td><\/tr> | Grand Total<\/p><\/td> | £37,900,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The amount of public dividend capital issued to the Trust by the Department is as follows:<\/p> <\/p> <\/p> <\/p> 2009/10<\/p><\/td> | £214,000<\/p><\/td><\/tr> | 2010/11<\/p><\/td> | £0<\/p><\/td><\/tr> | 2011/12<\/p><\/td> | £21,000,000<\/p><\/td><\/tr> | 2012/13<\/p><\/td> | £21,385,000<\/p><\/td><\/tr> | 2013/14<\/p><\/td> | £30,397,000<\/p><\/td><\/tr> | 2014/15<\/p><\/td> | £64,425,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The Department does not hold central records of non-tariff payments made by local commissioning bodies to NHS providers.<\/p> <\/p> <\/p> <\/p> The work of the trust special administrators (TSAs) to secure safe and sustainable services at Mid Staffordshire NHS Trust cost Monitor almost £19.5 million, including VAT, over 18 months.<\/p> <\/p> <\/p> <\/p> The first phase of trust special administration cost £9 million, including expenses and VAT. During this phase there was a team of up to 30 members of staff who carried out three core tasks - to help to run the Trust, to design the future of services provided at Stafford and Cannock hospitals, and to run a large public consultation involving thousands of responses and a series of public meetings.<\/p> <\/p> <\/p> <\/p> The second phase cost £10.5 million, including expenses and VAT. We are informed by Monitor that this second phase included a team of up to 50 people, which was required to continue to help run the hospital and implement the TSA\u2019s recommendations.<\/p> <\/p> <\/p> <\/p> We are also informed by Monitor that trust special administration at Mid-Staffordshire NHS Trust amounted to the rounded figure of 10,900 person-days for teams working on both phases of the process.<\/p> <\/p> <\/p> <\/p> In the table below, expenses incurred during the TSA process are split by the two phases of the TSA and totals are also provided. These expenses include:<\/p> <\/p> <\/p> <\/p> (a) accommodation;<\/p> <\/p> (b) travel (car, taxi and train);<\/p> <\/p> (c) subsistence; and<\/p> <\/p> (d) other expenses incurred; and what other costs to the TSA were incurred<\/p> <\/p> <\/p> <\/p> Breakdown of expenses, these exclude VAT:<\/p> <\/p> <\/p> <\/p> | <\/td> | TSA1<\/p><\/td> | TSA2<\/p><\/td> | Total<\/p><\/td><\/tr> | Accommodation<\/p><\/td> | £82,242.89<\/p><\/td> | £170,622.67<\/p><\/td> | £252,865.56<\/p><\/td><\/tr> | Travel<\/p><\/td> | £144,122.38<\/p><\/td> | £226,600.29<\/p><\/td> | £370,722.67<\/p><\/td><\/tr> | Subsistence<\/p><\/td> | £16,171.73<\/p><\/td> | £43,176.88<\/p><\/td> | £59,348.61<\/p><\/td><\/tr> | Other (incidentals such as printing, room hire and meeting refreshments)<\/p><\/td> | £1,939.11<\/p><\/td> | £3052.73<\/p><\/td> | £4991.84<\/p><\/td><\/tr> | Total<\/p><\/td> | £244,476.11<\/p><\/td> | £443,452.57<\/p><\/td> | £687,928.68<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-03-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/224727/answer/previousversion/49059", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2015-03-10T17:13:10.44Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-17T16:58:03.727Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: West Midlands"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much his Department has provided to implement the recommendations of the Trust Special Administration of Mid-Staffordshire NHS Foundation Trust on (a) capital investment in Stafford Hospital, (b) capital investment in Royal Stoke University Hospital, (c) capital investment in Cannock Hospital, (d) capital investment in New Cross Hospital, (e) other capital investment, (f) revenue support for the University Hospitals of the North Midlands NHS Trust, (g) revenue support for the Royal Wolverhampton Hospitals Trust and (h) other revenue support.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4109", "label" : {"_value" : "Biography information for Jeremy Lefroy"}
}
, "tablingMemberConstituency" : {"_value" : "Stafford"}
, "tablingMemberPrinted" : [{"_value" : "Jeremy Lefroy"}
], "uin" : "226012"}
, {"_about" : "http://data.parliament.uk/resources/224735", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/224735/answer", "answerText" : {"_value" : " Clinical commissioning group (CCG) funding has not been decided beyond 2015/16. Notified revenue allocations and per capita allocations for Cumbria CCG are:<\/p> <\/p> <\/p> <\/p> Year<\/p><\/td> | Allocation £000<\/p><\/td> | Per capita £<\/p><\/td><\/tr> | 2013/14<\/p><\/td> | 692,122<\/del><\/p>663,133<\/ins><\/p><\/td>1,330<\/del><\/p>1,274<\/ins><\/p><\/td><\/tr>2014/15<\/p><\/td> | 677,324<\/p><\/td> | 1,299<\/p><\/td><\/tr> | 2015/16<\/p><\/td> | 685,654<\/p><\/td> | 1,313<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> These figures exclude running cost and Better Care Fund allocations.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2015-03-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/224735/answer/previousversion/48371", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
}
, "questionFirstAnswered" : [{"_value" : "2015-03-06T14:39:07.327Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-19T18:02:16.817Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Clinical Commissioning Groups: Cumbria"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what funding (a) in total and (b) per capita has been allocated for Cumbria Clinical Commissioning Group for each year from 2013-14 to 2019-20.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1503", "label" : {"_value" : "Biography information for Mr Jamie Reed"}
}
, "tablingMemberConstituency" : {"_value" : "Copeland"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jamie Reed"}
], "uin" : "226114"}
, {"_about" : "http://data.parliament.uk/resources/224870", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/224870/answer", "answerText" : {"_value" : " The last period for which complete figures are available is the 2013-14 financial-year i.e. 12 months ended 31 March 2014. The table below details the proportion (%) of undisputed payments made, by individual body:<\/p> <\/p> <\/p> <\/p> Body<\/p><\/td> | Proportion of invoices paid within 5 days<\/p> (% to nearest 1%)<\/p><\/td><\/tr> | Department of Health<\/p><\/td> | 95<\/p><\/td><\/tr> | Medicines and Healthcare Products Regulatory Agency<\/p><\/td> | 76<\/p><\/td><\/tr> | Human Tissue Authority<\/p><\/td> | 95<\/p><\/td><\/tr> | Monitor<\/p><\/td> | 92<\/del>0*<\/ins><\/p><\/td><\/tr>Public Health England<\/p><\/td> | 81<\/p><\/td><\/tr> | Care Quality Commission<\/p><\/td> | 89<\/p><\/td><\/tr> | NHS Litigation Authority<\/p><\/td> | 13<\/p><\/td><\/tr> | Health Education England<\/p><\/td> | 2<\/p><\/td><\/tr> | Health Research Authority<\/p><\/td> | 6<\/p><\/td><\/tr> | Health and Social Care Information Centre<\/p><\/td> | 16<\/p><\/td><\/tr> | National Institute for Health & Care Excellence<\/p><\/td> | 6<\/p><\/td><\/tr> | NHS Blood and Transplant<\/p><\/td> | 24<\/p><\/td><\/tr> | NHS Property Services<\/p><\/td> | 0<\/p><\/td><\/tr> | NHS Business Services Authority<\/p><\/td> | 24<\/p><\/td><\/tr> | NHS England<\/p><\/td> | 54<\/p><\/td><\/tr><\/tbody><\/table> *Monitor return is 0% because it works towards paying all valid invoices within 10 working days not five. The 10-day compliance for 2013-14 was 92%.<\/ins><\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-03-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/224870/answer/previousversion/49032", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2015-03-10T16:36:28.883Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-16T17:31:17.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Billing"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what proportion of undisputed invoices his Department and its agencies and non-departmental public bodies paid within five days in the last period for which figures are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4128", "label" : {"_value" : "Biography information for Chuka Umunna"}
}
, "tablingMemberConstituency" : {"_value" : "Streatham"}
, "tablingMemberPrinted" : [{"_value" : "Mr Chuka Umunna"}
], "uin" : "226077"}
, {"_about" : "http://data.parliament.uk/resources/222966", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/222966/answer", "answerText" : {"_value" : " The Health and Social Care Information Centre advise that the collection of data for the Child and Adolescent Mental Health Services dataset will start at the beginning of February 2016. The first submission period will cover January to March 2016. Statistical reports based on the initial data collection will be published in mid-2016.<\/ins><\/p> <\/p> <\/p> <\/p> The National Institute for Health and Care Excellence guidance Multiple sclerosis: management of multiple sclerosis in primary and secondary care<\/em>, updated in October 2014, sets out best practice on the diagnosis, treatment, care and support of people with multiple sclerosis (MS). The guidance makes a range of recommendations on drug based treatments for MS, but also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. <\/del><\/p> <\/p> <\/p> <\/ins><\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> With regard to early diagnosis, MS is a difficult condition to diagnose as a number of the symptoms such as fatigue, depression or dizziness may be unrelated. The guidance sets out a number of initial presentations that clinicians should be aware of when looking for signs of MS. It also recommends a number of assessments a clinician should make, including testing of vision and blood tests before referral to a consultant neurologist, who can confirm or exclude a diagnosis of MS, subject to investigation.<\/del><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "answeringMemberConstituency" : {"_value" : "North Norfolk"}
, "answeringMemberPrinted" : {"_value" : "Norman Lamb"}
, "dateOfAnswer" : {"_value" : "2015-02-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/222966/answer/previousversion/46777", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "answeringMemberConstituency" : {"_value" : "North Norfolk"}
, "answeringMemberPrinted" : {"_value" : "Norman Lamb"}
}
, "questionFirstAnswered" : [{"_value" : "2015-02-26T15:20:43.73Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-02-27T13:56:12.937Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mental Health Services: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when he expects that the Child and Adolescent Mental Health Services Dataset will start publishing data; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "225018"}
, {"_about" : "http://data.parliament.uk/resources/178160", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/178160/answer", "answerText" : {"_value" : " The following tables show the number of admissions to hospital with a primary and secondary diagnosis of coronary heart disease by primary care trust of treatment for the years 2004/05 to 2012/13; by clinical commissioning group of treatment for 2013/14 and for England as a whole.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/178160/answer/attachment/1", "fileName" : {"_value" : "Hospital Admissions data.xlsx"}
, "title" : "No. of adnissions - CHD"}
, "dateOfAnswer" : {"_value" : "2015-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/178160/answer/previousversion/45133", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2015-02-12T15:52:16.67Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-02-12T16:09:16.33Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Heart Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many admissions to hospital with a (a) primary and (b) secondary diagnosis of coronary heart disease per head of population there were in (i) each clinical commissioning group and its predecessor organisation and (ii) England in each of the last 10 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/204", "label" : {"_value" : "Biography information for Paul Burstow"}
}
, "tablingMemberConstituency" : {"_value" : "Sutton and Cheam"}
, "tablingMemberPrinted" : [{"_value" : "Paul Burstow"}
], "uin" : "223598"}
, {"_about" : "http://data.parliament.uk/resources/177981", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/177981/answer", "answerText" : {"_value" : " Exposure to secondhand smoke is a serious health hazard. More than 50 carcinogens have been identified in secondhand smoke.<\/p> <\/p> <\/p> <\/p> The report of the United States Surgeon General titled \u201cThe health consequences of involuntary exposure to tobacco smoke\u201d<\/em> concluded that secondhand smoke causes premature death and disease in children and adults who do not smoke. The scientific evidence indicates that there is no risk-free level of exposure to secondhand smoke. Children exposed to secondhand smoke are at an increased risk for sudden infant death syndrome, acute respiratory infections, ear problems and more severe asthma. Smoking by parents causes respiratory symptoms and slows lung growth in children. Exposure of adults to secondhand smoke has immediate adverse effects on the cardiovascular system and causes coronary heart disease and lung cancer. Legislation to stop smoking in vehicles carrying children will come into force in England on 1 October 2015.<\/p> <\/p>
The report of the Royal College of Physicians <\/ins>Surgeons<\/del> titled \u201cGoing smoke-free: The medical case for clean air in the home, at work and in public places\u201d<\/em> included estimates that secondhand smoke exposure caused approximately 122<\/del>,200 deaths in the United Kingdom in 2003, and that the majority of these deaths occurred as a result of exposure to secondhand smoke in the home. These estimates were made prior to the introduction of smokefree legislation in England in 2007. Over the past decade, the proportion of smokers who say that they do not smoke in the home has increased.<\/p> <\/p> <\/p> <\/p> The evidence is clear that smokefree legislation in England has had beneficial effects on health, as set out in the report \u201cThe Impact of smokefree legislation in England: evidence review\u201d<\/em> which was published alongside the Government\u2019s \u201cTobacco Control Plan for England\u201d<\/em> in March 2011.<\/p> <\/p> <\/p> <\/p> The reports referred to have been placed in the Library.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
}
, "answeringMemberPrinted" : {"_value" : "Earl Howe"}
, "dateOfAnswer" : {"_value" : "2015-02-17", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/177981/answer/previousversion/45462", "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
}
, "answeringMemberPrinted" : {"_value" : "Earl Howe"}
}
, "questionFirstAnswered" : [{"_value" : "2015-02-17T16:08:25.233Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-03-12T12:34:25.527Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Passive Smoking"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty\u2019s Government what is their estimate of the number of people who died as a result of passive smoking in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/2479", "label" : {"_value" : "Biography information for Lord Laird"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Laird"}
], "uin" : "HL4692"}
, {"_about" : "http://data.parliament.uk/resources/176781", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/176781/answer", "answerText" : {"_value" : " NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.<\/p> <\/p> <\/p> <\/p> NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.<\/p> <\/p> <\/p> <\/p> NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.<\/p> <\/p> <\/p> <\/p> NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.<\/p> <\/p> <\/p> <\/p> Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "attachment" : [{"_about" : "http://data.parliament.uk/resources/176781/answer/attachment/1", "fileName" : {"_value" : "nhs-england-and-ccg-regulations.pdf"}
, "title" : "Regulations NHS Commissioning Board & CCGs"}
, {"_about" : "http://data.parliament.uk/resources/176781/answer/attachment/2", "fileName" : {"_value" : "pss-manual.pdf"}
, "title" : "Manual prescribed specialised services"}
], "dateOfAnswer" : {"_value" : "2015-02-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/176781/answer/previousversion/42619", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2015-02-03T15:09:14.61Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-02-03T15:20:37.267Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether joint committees of NHS England and clinical commissioning groups are permitted to deviate from national service specifications for specialised services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4076", "label" : {"_value" : "Biography information for Valerie Vaz"}
}
, "tablingMemberConstituency" : {"_value" : "Walsall South"}
, "tablingMemberPrinted" : [{"_value" : "Valerie Vaz"}
], "uin" : "222695"}
, {"_about" : "http://data.parliament.uk/resources/176783", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/176783/answer", "answerText" : {"_value" : " NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.<\/p> <\/p> <\/p> <\/p> NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.<\/p> <\/p> <\/p> <\/p> NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.<\/p> <\/p> <\/p> <\/p> NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.<\/p> <\/p> <\/p> <\/p> Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "attachment" : [{"_about" : "http://data.parliament.uk/resources/176783/answer/attachment/1", "fileName" : {"_value" : "nhs-england-and-ccg-regulations.pdf"}
, "title" : "Regulations NHS Commissioning Board & CCGs"}
, {"_about" : "http://data.parliament.uk/resources/176783/answer/attachment/2", "fileName" : {"_value" : "pss-manual.pdf"}
, "title" : "Manual prescribed specialised services"}
], "dateOfAnswer" : {"_value" : "2015-02-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/176783/answer/previousversion/42620", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2015-02-03T15:09:14.753Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-02-03T15:21:10.413Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when NHS England will publish details of the co-commissioning of specialised services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4076", "label" : {"_value" : "Biography information for Valerie Vaz"}
}
, "tablingMemberConstituency" : {"_value" : "Walsall South"}
, "tablingMemberPrinted" : [{"_value" : "Valerie Vaz"}
], "uin" : "222693"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-answer.questionFirstMinisteriallyCorrected.=2014-11-10T17%3A38%3A55.2793146Z&AnsweringBody.=Department+of+Health&answeringDeptSortName=Health&max-answer.dateOfAnswer=2015-03-10", "page" : 0, "startIndex" : 1, "totalResults" : 33, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|